COMPANY
Clinical Phase 2
Keywords: dermatology androgenic alopecia alopecia areata Androgenetic Alopecia
Location: Wilmington, DE · source · Oct 15, 2026
Profile checked Oct 10, 2026
Timeline
- Partnership Partnership / licensing announced May 30, 2025. Source: company's own press page. source ↗
- Trial start Phase 1/Phase 2: Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men source ↗
Funding
Last 2 years.
- Partnership / licensing announced May 30, 2025. Source: company's own press page. source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT05636904 | Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men | Phase 1/Phase 2 | Completed | Dec 5, 2022 | Mar 28, 2024 (actual) |